Search Results - "Watt, Julie C"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells by Ruvolo, Peter P., Zhou, Liran, Watt, Julie C., Ruvolo, Vivian R., Burks, Jared K., Jiffar, Tilahun, Kornblau, Steven, Konopleva, Marina, Andreeff, Michael

    Published in Journal of cellular biochemistry (01-06-2011)
    “…Recent studies in acute myeloid leukemia (AML) suggest activation of pro‐proliferative signaling cascades including those mediated by protein kinase C (PKC)…”
    Get full text
    Journal Article
  3. 3

    Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK by Nica, Alina Felicia, Tsao, Chun Chui, Watt, Julie C., Jiffar, Tilahun, Kurinna, Svitlana, Jurasz, Paul, Konopleva, Marina, Andreeff, Michael, Radomski, Marek W., Ruvolo, Peter P.

    Published in Cell cycle (Georgetown, Tex.) (01-11-2008)
    “…Ceramide is a sphingolipid that activates stress kinases such as p38 and c-JUN N-Terminal Kinase (JNK). Though Chronic Myelogenous Leukemia (CML) derived K562…”
    Get full text
    Journal Article
  4. 4
  5. 5

    PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL by Tabe, Yoko, Konopleva, Marina, Kondo, Yutaka, Contractor, Rooha, Tsao, Twee, Konoplev, Sergej, Shi, Yuexi, Ling, Xiaoyang, Watt, Julie C., Tsutsumi-Ishii, Yuko, Ohsaka, Akimichi, Nagaoka, Isao, Issa, Jean-Pierre, Kogan, Scott C., Andreeff, Michael

    Published in Cancer biology & therapy (01-12-2007)
    “…Acute promyelocytic leukemia (APL) is associated with oncogenic PML-RARα that acts as a dominant negative transcriptional repressor of retinoic acid (RA)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells by Samudio, Ismael J., Duvvuri, Seshagiri, Clise-Dwyer, Karen, Watt, Julie C., Mak, Duncan, Kantarjian, Hagop, Yang, Dajun, Ruvolo, Vivian, Borthakur, Gautam

    Published in Leukemia & lymphoma (01-05-2010)
    “…Non-mutational inactivation of p53 is frequent in acute myeloid leukemia (AML) via overexpression of MDM2. We report that treatment with MI-63, a novel…”
    Get full text
    Journal Article
  8. 8

    Cellular Transformation by the HTLV-I Tax Protein, a Jack-of-All-Trades by Gatza, Michael L, Watt, Julie C, Marriott, Susan J

    Published in Oncogene (11-08-2003)
    “…The human T-cell leukemia virus type I (HTLV-I) is an oncogenic retrovirus that is responsible for adult T-cell leukemia and a neurological disease,…”
    Get full text
    Journal Article
  9. 9

    Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis by MOORE, Lynette, VENKATACHALAM, Sundaresan, VOGEL, Hannes, WATT, Julie C, WU, Chao-Ling, STEINMAN, Heather, JONES, Stephen N, DONEHOWER, Lawrence A

    Published in Oncogene (30-10-2003)
    “…The p19ARF gene product responds to oncogenic stresses by interfering with the inhibitory effects of Mdm2 on p53, thus enhancing p53 activity and its…”
    Get full text
    Journal Article
  10. 10

    Targeting IL3 Receptor in Chronic Myeloid Leukemia by Frolova, Olga, Wang, Rui-Yu, Korchin, Borys, Watt, Julie C., Cortes, Jorge, Frankel, Arthur E., Kantarjian, Hagop M., Andreeff, Michael, Konopleva, Marina

    Published in Blood (20-11-2009)
    “…Abstract 2172 Poster Board II-149 Despite the great success of imatinib therapy in chronic myeloid leukemia (CML), the presence of a residual leukemic clone is…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Activation of p53 signaling by MI-63 induces apoptosis in acute myelogenous leukemia cells by Samudio, Ismael J, Duvvuri, Seshagiri, Clise-Dwyer, Karen, Watt, Julie C, Mak, Duncan, Kantarjian, Hagop, Yang, Dajun, Ruvolo, Vivian, Borthakur, Gautam

    Published in Leukemia & lymphoma (01-05-2010)
    “…Non-mutational inactivation of p53 is frequent in acute myeloid leukemia (AML) via overexpression of MDM2. We report that treatment with MI-63, a novel…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Inhibition of Bcl-2 Signaling by Small Molecule BH3 Inhhibitor GX15-070 as a Novel Therapeutic Strategy in AML by Watt, Julie C., Konopleva, Marina, Contractor, Rooha, Samudio, Ismael, Harris, David, Estrov, Zeev, Viallet, Jean, Andreeff, Michael

    Published in Blood (16-11-2006)
    “…GX15-070 is a novel cycloprodigiosin derived small molecule BH3 inhibitor that binds with moderate affinity to all antiapoptotic Bcl-2 family members,…”
    Get full text
    Journal Article
  16. 16

    A Novel Peptide Containing a Nine Amino Acid Sequence from Nur77 Induces Bcl-2-Dependent Apoptosis in AML by Andreeff, Michael, Konopleva, Marina, Watt, Julie C., Samudio, Ismael J., Satterthwait, Arnold C., Kitada, Shinichi, Zhang, Xiao-kun, Reed, John C.

    Published in Blood (16-11-2006)
    “…Nur77 (also known as TR3 and NGFI-B) is a nuclear orphan receptor that in response to various stimuli can translocate from the nucleus to the mitochondria,…”
    Get full text
    Journal Article
  17. 17